Almac Expands Commercial Packaging Facility

Article

PTSM: Pharmaceutical Technology Sourcing and Management

PTSM: Pharmaceutical Technology Sourcing and ManagementPTSM: Pharmaceutical Technology Sourcing and Management-12-07-2016
Volume 11
Issue 12

The company expanded its commercial packaging facility in response to a growing demand for pediatric drugs.

On Nov. 14, 2016 Almac Group announced that the company has expanded its MHRA/FDA-approved United Kingdom commercial packaging facility with the acquisition of a stick sachet packing line from Merz. The acquisition comes in response to growing demand for the specialist packaging solutions for pediatric drug products, specifically powders, minitabs, or granules into stickpack sachets, Almac said in a press announcement.

This investment was made in partnership with a long-term commercial US client who sought an integrated commercial manufacturing and packaging solution for the EU supply of their new pediatric formulation drug product. In line with EU Paediatric Regulations (EC1901/2006 and EC1902/2006), the US client implemented its pediatric investigation plan (PIP) and developed and launched an age appropriate formulation to meet infant patient needs, with Almac manufacturing the pediatric granules and performingprimary packing into stickpack sachets and then into wallet cards.

The Merz SBL-50 stickpack technology is a fully automated forming, filling, and sealing machine capable of filling 80 stickpacks per minute. This flexible technology has capacity to process new pediatric drug products (powders, granules, and minitabs) that require this specialist packaging.

Source: Almac

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content